SCHEMBL20667974

SCHEMBL20667974

CCCCNc1nc(C)nc2sc(C)cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ CRHR1 P34998 2/20 0.43
▸ L3MBTL1 Q9Y468 3/20 0.41
▸ LMNA P02545 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ CHEK2 O96017 1/20 0.41
▸ FLT1 P17948 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ ACP1 P24666 1/20 0.39
▸ TLR8 Q9NR97 3/20 0.38
▸ TLR7 Q9NYK1 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ CASP6 P55212 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ GALR3 O60755 1/20 0.36
▸ NR2F2 P24468 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20668004 0.86 ALDH1A1 (0.41) KDM4EALDH1A1HSD17B10L3MBTL1CHEK2
SCHEMBL5439734 0.85 KDM4E (0.45) KDM4EALDH1A1HSD17B10CRHR1L3MBTL1
SCHEMBL24305698 0.83 KDM4E (0.44) KDM4EALDH1A1HSD17B10CRHR1L3MBTL1
SCHEMBL20668008 0.82 TLR7 (0.46) KDM4EALDH1A1HSD17B10LMNASMN1; SMN2
SCHEMBL20668111 0.81 KDM4E (0.43) KDM4EALDH1A1HSD17B10CRHR1L3MBTL1
SCHEMBL20667984 0.81 ALDH1A1 (0.46) KDM4EALDH1A1HSD17B10LMNASMN1; SMN2
SCHEMBL20667999 0.80 JAK2 (0.40) KDM4EALDH1A1HSD17B10CHEK2FLT1
SCHEMBL20668115 0.80 CHEK2 (0.36) KDM4EALDH1A1HSD17B10CRHR1LMNA
SCHEMBL5423226 0.80 ALDH1A1 (0.45) KDM4EALDH1A1HSD17B10L3MBTL1LMNA
SCHEMBL5429124 0.80 KDM4E (0.49) KDM4EALDH1A1HSD17B10L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220117968-A1 THIENO[2,3-D)PYRIMIDINES AND BENZOFURO(3,2-D)PYRIMIDINES AS ANTIMICROBIAL AGENTS SAINT LOUIS UNIVERSITY 2022-04-21 — — US disclosed
WO-2019018359-A1 THIENO[2,3-D)PYRIMIDINES AND BENZOFURO(3,2-D)PYRIMIDINES AS ANTIMICROBIAL AGENTS SAINT LOUIS UNIVERSITY (US) 2019-01-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220117968-A1 THIENO[2,3-D)PYRIMIDINES AND BENZOFURO(3,2-D)PYRIMIDINES AS ANTIMICROBIAL AGENTS TYMS, DPYD, UMPS KDM4E 2186/4885ALDH1A1 924/4885HSD17B10 2770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback